KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Revenue History
Annual and quarterly revenue from 2020 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
KMTS Revenue Growth
KMTS Revenue Analysis (2020–2025)
As of May 8, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) generated trailing twelve-month (TTM) revenue of $83.7 million, reflecting explosive growth of +62.7% year-over-year. The most recent quarter (Q3 2026) recorded $24.6 million in revenue, up 8.8% sequentially.
Looking at the longer-term picture, KMTS's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $59.8 million in 2025, representing a new all-time high.
When compared to Healthcare sector peers including MDT (+6.9% YoY), ABT (+6.4% YoY), and BSX (+19.9% YoY), KMTS has outperformed the peer group in terms of revenue growth. Compare KMTS vs MDT →
KMTS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| KMTSCurrent | $84M | +62.7% | - | -177.8% | |
 MDT | $33.5B | +6.9% | +3.0% | 17.8% | |
 ABT | $42.0B | +6.4% | +5.6% | 16.3% | |
 BSX | $20.1B | +19.9% | +15.2% | 19.8% | |
 EW | $6.1B | +11.2% | +6.7% | 27.0% | |
 LIVN | $1.4B | +12.4% | +8.2% | 14.4% |
KMTS Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $59.8M | +115.1% | $24.2M | 40.5% | $-106,378,000 | -177.8% |
| 2024 | $27.8M | +264.5% | $362K | 1.3% | $-85,063,000 | -305.8% |
| 2023 | $7.6M | - | $-10,651,000 | -139.6% | $-80,421,000 | -1054.0% |
| 2021 | $0 | - | $0 | - | $-32,708,000 | - |
| 2020 | $0 | - | $0 | - | $-29,319,000 | - |
See KMTS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs KMTS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare KMTS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonKMTS — Frequently Asked Questions
Quick answers to the most common questions about buying KMTS stock.
Is KMTS's revenue growth accelerating or slowing?
KMTS revenue is accelerating at +62.7% year-over-year, exceeding the 5-year CAGR of N/A. TTM revenue reached $84M. Growth momentum has increased versus prior periods.
What is KMTS's long-term revenue growth rate?
KESTRA MEDICAL TECHNOLOGIES, LTD.'s 5-year revenue CAGR of N/A reflects the sustained expansion pattern. Current YoY growth of +62.7% is above this long-term average.
How is KMTS's revenue distributed by segment?
KMTS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.